Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

M Ángeles Domínguez1, Alex Soriano2

  • 1Servicio de Microbiología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.

Enfermedades Infecciosas Y Microbiologia Clinica
|January 29, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timing and microbiological profile influence long-term outcomes after debridement, antibiotics, and implant retention (DAIR) in acute hip periprosthetic joint infection.

Archives of orthopaedic and trauma surgery·2026
Same author

Use of Isavuconazole in the Treatment of Cryptococcosis: A Real-World Case Series.

Infectious diseases and therapy·2026
Same author

Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study.

JAC-antimicrobial resistance·2026
Same author

The Most Common Organisms in Periprosthetic Joint Infection: A Survey of the International Orthopaedic Device Infection Network.

The Journal of arthroplasty·2026
Same author

Defining the threshold duration of candidemia associated with poor outcomes: Redefining persistent candidemia.

The Journal of infection·2026
Same author

Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

Open forum infectious diseases·2026